US preorders COVID-19 vaccine and antibody therapy
Thursday, July 9, 2020 - 19:11
in Health & Medicine
Novavax will earn $1.6 billion for its vaccine and Regeneron $450 million for its antibodies
Novavax will earn $1.6 billion for its vaccine and Regeneron $450 million for its antibodies